Evidence map›Paper›PMID 40397255›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2025

Assessment of prostate cancer awareness and screening knowledge among men in Najran, Saudi Arabia: a cross-sectional study.

Yousif A Kariri

Abstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yousif A KaririDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia. Ykuriri@su.edu.sa.ORCID http://orcid.org/0000-0002-2507-2292

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is one of the most common male cancers and the second leading cause of cancer-related deaths among males worldwide. Efforts to increase men's awareness, understanding of the symptoms and risk factors, and provision of early medical assistance are crucial for the prevention and detection of PCa. This study assessed the level of awareness, knowledge, and screening for PCa among male participants in Najran, Saudi Arabia. A cross-sectional study was conducted with 341 male participants from 19 June 2024 to 25 September 2024. An online questionnaire was used to collect data. Bivariate data were analyzed and associations were considered significant when the p-value was ≤ 0.05. A total of 341 completed survey samples were collected. The mean age of the participants was 42 years (SD ± 8.17). The study found that most participants (70.4%) had adequate knowledge of PCa. However, only 30.5% were aware of the prostate-specific antigen (PSA) test, while a small minority (3.2%) had visited a specialized physician regarding PCa. The findings suggest that about 70% of male participants in Najran, Saudi Arabia, have an adequate level of awareness regarding the risk factors and screening for PCa. Recommendations include organizing more awareness campaigns, sharing information on social media, encouraging men to undergo screening tests, providing health education to primary care physicians and public-based organizations, and conducting further studies with larger numbers of participants to increase PCa awareness in Najran Province, Saudi Arabia.

Indexed as

AttitudeAwarenessKnowledgeProstate-specific antigenPublic healthRisk factors

Identifiers

PMID40397255
PMCPMC12102043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.